Ignite Creation Date:
2024-05-06 @ 8:14 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06301048
Status:
COMPLETED
Last Update Posted:
2024-03-08
First Post:
2024-02-18
Brief Title:
Effectiveness of Endoscopic Papillectomy With Stent for Treating Duodenal Papillary Adenoma
Sponsor:
Beijing Friendship Hospital
Organization:
Beijing Friendship Hospital
Study Overview
Official Title:
Effectiveness of Endoscopic Papillectomy With Stent Placement in Pancreatic and Bile Ducts for Treating Duodenal Papillary Adenoma
Status:
COMPLETED
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a retrospective study including 79 patients with duodenal papillary adenoma who treated with Endoscopic Papillectomy EP at Beijing friendship hospital The cohort included patients who underwent EP with or without Pancreatic Duct PD and Common Bile Duct CBD stent placement The investigators assessed the outcomes of EP and the impact of stent placement on complications and recurrence rates
Detailed Description:
Duodenal papillary adenoma a potentially malignant benign tumor is primarily treated with endoscopic papillectomy Despite its efficacy endoscopic papillectomy has a high complication rate This study investigates whether pancreatic duct and common bile duct stent placement can mitigate these complications In a retrospective analysis 79 patients with duodenal papillary adenoma treated with endoscopic papillectomy at our center were studied The cohort included patients who underwent endoscopic papillectomy with no stents placement common bile duct stent placement alone pancreatic duct stent placement alone or stents placement in both ducts Complete resection rates did not significantly differ between patients with or without stent placement Early complication rates were similar across groups However significant reduction in common bile duct stenosis was observed in the stenting group Furthermore stent placement correlated with lower adenoma recurrence rates during follow-up Thus Pancreatic duct and common bile duct stent placement in endoscopic papillectomy may decrease late complications particularly common bile duct stenosis and reduce the recurrence of duodenal papillary adenoma
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None